Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹3.13Admitted-Finance | L1 | Admitted-Finance | |
| 2 | L2₹4.44+₹1.31 (41.9%)Admitted-Finance PLOT NO 2117 A 2 PHASE II II G I D C VAPI GUJARAT INDIA 396195 | VAPI | VALSAD | GUJARAT | 396195 | L2 | Admitted-Finance |
| Sl No | Description | Qty | Unit | MicronPharmaceuticals L2 | J.Duncan Healthcare Pvt. Ltd. L1 |
|---|---|---|---|---|---|
| 1.00Medical Equipment | |||||
| 1.01 | Rifampicin 150 mg | 1 | One | - | - |
| 1.02 | Rifampicin 300 mg | 1 | One | - | - |
| 1.03 | Pyrazinamide 500 mg | 1 | One | 1.98 ₹2.08 | 1.2 ₹1.34 Lowest |
| 1.04 | Pyrazinamide 750 mg | 1 | One | 2.25 ₹2.36 | 1.6 ₹1.79 Lowest |
| 1.05 | Tab. Isoniazid 100 Mg | 1 | One | - | - |
| 1.06 | Tab. Isoniazid 300 Mg | 1 | One | - | - |
Tender Value
Refer Docs
Closing Date
21 Apr 2023, 10:30 amClosed
Managing Director
PHSC, Phase 8, SAS Nagar
Supply of Medicines under NTEP
2023_DHFW_100137_2
PHSC/Proc/NTEP/2023/51
Open Tender
Consumables (Hospital / Lab)
Item Wise
60 days
PHSC, Phase 8, SAS Nagar
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
Exempted
Committee Room
3 Sept 2025
31 Mar 2023
21 Apr 2023
31 Mar 2023
21 Apr 2023
10 Apr 2023
6 Apr 2023
Medical Equipment
Rifampicin 150 mg
Rifampicin 300 mg
Pyrazinamide 500 mg
Pyrazinamide 750 mg
Tab. Isoniazid 100 Mg
Tab. Isoniazid 300 Mg
MicronPharmaceuticals
stage.html
html • 0.03 MB
tech_bid_open.pdf
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .